Gene Disease Score gda Association Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 116
Gene Symbol: ADCYAP1
ADCYAP1
High-Grade Squamous Intraepithelial Lesions
0.010 PosttranslationalModification BEFREE ADCYAP1 and PAX1 also trended toward elevated methylation levels in HSIL samples, although the levels were much lower than those in cancer cells. 26768780

2016

Entrez Id: 207
Gene Symbol: AKT1
AKT1
High-Grade Squamous Intraepithelial Lesions
0.010 AlteredExpression BEFREE Up-regulation of AKT activity and loss of Rb was also observed in HPV-positive cervical high-grade squamous intraepithelial lesions when compared with normal cervical tissue. 16740689

2006

Entrez Id: 261
Gene Symbol: AMCN
AMCN
High-Grade Squamous Intraepithelial Lesions
0.010 GeneticVariation BEFREE Reliability and between-group stability of a health-related quality of life symptom index for persons with anal high-grade squamous intraepithelial lesions: an AIDS Malignancy Consortium Study (AMC-A03). 30617704

2019

Entrez Id: 367
Gene Symbol: AR
AR
High-Grade Squamous Intraepithelial Lesions
0.010 Biomarker BEFREE Of the 160 women included, 111 were diagnosed with atypical glandular cells, 35 had both atypical glandular cells and high-grade squamous intraepithelial lesions, whereas 14 women had AIS, in 1 case associated with high-grade squamous intraepithelial lesions. 19620946

2009

Entrez Id: 83478
Gene Symbol: ARHGAP24
ARHGAP24
High-Grade Squamous Intraepithelial Lesions
0.010 Biomarker BEFREE This is in agreement with the possible role of p73 in cervical carcinogenesis, namely, in human papillomavirus-infected transition zone subjected to the action of estrogens and in conjunction with disruption of differentiation program of this squamous epithelium that occurs in HSIL phase before the next step to invasiveness and squamous cervical cancer. 21711160

2012

Entrez Id: 8289
Gene Symbol: ARID1A
ARID1A
High-Grade Squamous Intraepithelial Lesions
0.010 AlteredExpression BEFREE Lower levels of the ARID1A expression were detected in cases with adenosquamous carcinomas (60%), low- or high-grade squamous intraepithelial lesion (SIL) (31%), and squamous cell carcinomas (18.5%). 26303865

2015

Entrez Id: 573
Gene Symbol: BAG1
BAG1
High-Grade Squamous Intraepithelial Lesions
0.010 AlteredExpression BEFREE BAG-1 expression levels were significantly different between LSILs and HSILs (p = 0,014) and between LSILs and SCCs (p = 0,014). 22454210

2012

Entrez Id: 596
Gene Symbol: BCL2
BCL2
High-Grade Squamous Intraepithelial Lesions
0.010 AlteredExpression BEFREE To establish the role of co-overexpression of bcl-2 and c-myc protooncogenes in uterine cervix carcinogenesis, we examined 138 tissue samples of low grade cervical squamous intraepithelial lesions (SIL), high grade SIL, portio vaginalis uteri (PVU) carcinoma in situ and PVU carcinoma invasive, stage IA-IIA (study group) and 36 samples without SIL or malignancy (control group). 21556123

2011

Entrez Id: 648
Gene Symbol: BMI1
BMI1
High-Grade Squamous Intraepithelial Lesions
0.010 AlteredExpression BEFREE Expression of Bmi1 protein gradually increased across samples from the normal cervix (1/47; 2.12%), high‑grade squamous intraepithelial lesions (5/42; 16.13%) and cervical carcinomas (31/71; 43.66%; P<0.05). 31173263

2019

Entrez Id: 23476
Gene Symbol: BRD4
BRD4
High-Grade Squamous Intraepithelial Lesions
0.020 Biomarker BEFREE However, for reasons of considerable inter-observer variation in CIN grade assignment and for want of a biomarker validating a three-fold stratification, CAP-ASCCP LAST consensus guidelines recommend a two-tier system: low- or high-grade squamous intraepithelial lesions (LSIL or HSIL). 24625757

2014

Entrez Id: 23476
Gene Symbol: BRD4
BRD4
High-Grade Squamous Intraepithelial Lesions
0.020 Biomarker BEFREE p16 immunohistochemistry is recommended by the CAP-ASCCP Lower Anogenital Squamous Terminology (LAST) Standardization Project for human papillomavirus associated Lesions as an adjunct to morphologic assessment in the diagnosis of high-grade squamous intraepithelial lesion. 28863068

2018

Entrez Id: 1620
Gene Symbol: BRINP1
BRINP1
High-Grade Squamous Intraepithelial Lesions
0.010 Biomarker BEFREE Furthermore, WT1, NKX6-1 and DBC1 genes were hypermethylated in the high-grade squamous intraepithelial lesion (CIN2, CIN3) and in the cervical cancer tissues with infection of HPV16/18 (both P< 0.05). 29658966

2019

Entrez Id: 701
Gene Symbol: BUB1B
BUB1B
High-Grade Squamous Intraepithelial Lesions
0.010 AlteredExpression BEFREE The expression of Mad2 was significantly lower in HSIL than those in chronic cervicitis and LSIL, however, the expression of BubR1 showed no significant differences. 31523901

2019

Entrez Id: 23705
Gene Symbol: CADM1
CADM1
High-Grade Squamous Intraepithelial Lesions
0.040 PosttranslationalModification BEFREE The aim of this study was to prospectively evaluate the methylation status of CADM 1, MAL and hsa-miR-124 genes in high-grade squamous intraepithelial lesion (HSIL) liquid-based cytology (LBC) samples with a histological correlation. 31074057

2019

Entrez Id: 23705
Gene Symbol: CADM1
CADM1
High-Grade Squamous Intraepithelial Lesions
0.040 PosttranslationalModification BEFREE Specifically, methylation of IGSF4 and DAPK1 was prevalent in SCC (75% and 75% of cases, respectively) and HSIL (59% and 71%, respectively) but was absent in LSIL and normal biopsy samples. 16166431

2005

Entrez Id: 23705
Gene Symbol: CADM1
CADM1
High-Grade Squamous Intraepithelial Lesions
0.040 Biomarker BEFREE This suggests a possible role of genomic DNA methylation, especially CADM1, in detecting histologic HSIL+ lesions in combination with hrHPV testing. 30608989

2019

Entrez Id: 23705
Gene Symbol: CADM1
CADM1
High-Grade Squamous Intraepithelial Lesions
0.040 Biomarker BEFREE The areas under the curve for the best two-gene combination (IGSF4/DAPK1) and the best three-gene combination (IGSF4/DAPK1/HIC1) were not statistically different from the best individual tumor suppressor gene (IGSF4) in distinguishing HSIL samples from combined LSIL/negative samples. 15368319

2004

Entrez Id: 10487
Gene Symbol: CAP1
CAP1
High-Grade Squamous Intraepithelial Lesions
0.020 Biomarker BEFREE However, for reasons of considerable inter-observer variation in CIN grade assignment and for want of a biomarker validating a three-fold stratification, CAP-ASCCP LAST consensus guidelines recommend a two-tier system: low- or high-grade squamous intraepithelial lesions (LSIL or HSIL). 24625757

2014

Entrez Id: 10487
Gene Symbol: CAP1
CAP1
High-Grade Squamous Intraepithelial Lesions
0.020 Biomarker BEFREE p16 immunohistochemistry is recommended by the CAP-ASCCP Lower Anogenital Squamous Terminology (LAST) Standardization Project for human papillomavirus associated Lesions as an adjunct to morphologic assessment in the diagnosis of high-grade squamous intraepithelial lesion. 28863068

2018

Entrez Id: 6347
Gene Symbol: CCL2
CCL2
High-Grade Squamous Intraepithelial Lesions
0.010 AlteredExpression BEFREE Although preliminary, our observations lend support to the suggestion that the experimental model of transcriptional regulation and exclusion of either HPV E6/E7 or MCP-1 expression is especially pertinent to high-grade SIL, whereas in most SCCs, other environmental factors may influence this relationship. 8909236

1996

Entrez Id: 8900
Gene Symbol: CCNA1
CCNA1
High-Grade Squamous Intraepithelial Lesions
0.020 Biomarker BEFREE Furthermore, hypermethylated HS3ST2 and CCNA1 genes were correlated with infection with HPV16 and HPV18 in high-grade squamous intraepithelial lesions (HSILs) and cervical cancer (both p<0.05). 25198553

2014

Entrez Id: 8900
Gene Symbol: CCNA1
CCNA1
High-Grade Squamous Intraepithelial Lesions
0.020 Biomarker BEFREE However, frequency of methylation increases during cervical carcinogenesis, with CCNA1 and DAPK as the best markers to distinguish normal/LSIL from HSIL/cancer lesions. 20208141

2010

Entrez Id: 595
Gene Symbol: CCND1
CCND1
High-Grade Squamous Intraepithelial Lesions
0.010 GeneticVariation BEFREE We analyzed the A870G CCND1 polymorphism by polymerase chain reaction/restriction fragment length polymorphism analysis in 246 women including 50 cases with high-grade squamous intraepithelial lesions of the cervix (HSIL), 93 with ICC, and 103 healthy women. 15949570

2005

Entrez Id: 729230
Gene Symbol: CCR2
CCR2
High-Grade Squamous Intraepithelial Lesions
0.020 GeneticVariation BEFREE These findings suggest that CCR2-64I polymorphism might have a protective role in the evolution from high-grade SIL to ICC. 15721423

2005

Entrez Id: 729230
Gene Symbol: CCR2
CCR2
High-Grade Squamous Intraepithelial Lesions
0.020 GeneticVariation BEFREE Overall, the frequency of A carrier genotypes was higher in HSIL patients than in the control group (p = 0.013; OR = 2.21; 95%CI: 1.17-4.15), suggesting that CCR2-64I polymorphism might contribute to the establishment of HSIL, through the disruption of the naturally fragile immune response directed towards human papillomavirus infection. 17664883

2007